InsidersTradesSigma
Follow the Dogwood Therapeutics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on US US, under the authority of SEC (Form 4). The latest transaction was filed on 25 November 2025 (C). Among the most active insiders: Sealbond Ltd. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Dogwood Therapeutics, Inc. is a company focused on developing innovative treatments for neurological diseases. It is listed on the XNAS market.